Literature DB >> 19331846

Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.

Z Ding1, F J Verbaan, M Bivas-Benita, L Bungener, A Huckriede, D J van den Berg, G Kersten, J A Bouwstra.   

Abstract

Transcutaneous immunization (TCI) is limited by poor permeation of macromolecules across the skin. Microneedle arrays form transient conduits and enhance the transport of vaccine molecules across the skin barrier without pain sensation. Here we investigated in mouse the immune responses after TCI using two model antigens, diphtheria toxoid (DT) and influenza subunit vaccine. The electric applicator enabled shorter microneedle (300 microm) to pierce mouse skin effectively, as shown by Trypan blue staining and trans-epidermal water loss measurement. The vaccines were topically applied with and without cholera toxin (CT) on microneedle-treated skin. In DT TCI, microneedle array pretreatment of the skin was essential to achieve substantial IgG and toxin-neutralizing antibody titers. Addition of CT further boosted the immune response to similar levels as observed after subcutaneous injection of AlPO4-adsorbed DT (DT-alum). In contrast, microneedle array pretreatment showed no effect on the immune response to plain influenza vaccine. This response was strongly improved by inclusion of CT, independent of microneedle treatment. These results indicate that TCI of DT and CT with microneedle treatment results in comparable protection as injection of DT-alum, and TCI of influenza vaccine adjuvanted with CT is superior to the injection of plain vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331846     DOI: 10.1016/j.jconrel.2009.01.025

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  36 in total

1.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Novel antigen delivery technologies: a review.

Authors:  Deepika Jain; Vikas Jain; Ranjit Singh
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

Review 3.  Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.

Authors:  Sharifa Al-Zahrani; Marija Zaric; Cian McCrudden; Chris Scott; Adrien Kissenpfennig; Ryan F Donnelly
Journal:  Expert Opin Drug Deliv       Date:  2012-04-05       Impact factor: 6.648

Review 4.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

5.  Kinetics of skin resealing after insertion of microneedles in human subjects.

Authors:  Jyoti Gupta; Harvinder S Gill; Samantha N Andrews; Mark R Prausnitz
Journal:  J Control Release       Date:  2011-05-26       Impact factor: 9.776

6.  Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array.

Authors:  Zhi Ding; Suzanne M Bal; Stefan Romeijn; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-03-17       Impact factor: 4.200

Review 7.  Two-photon polymerization of microneedles for transdermal drug delivery.

Authors:  Shaun D Gittard; Aleksandr Ovsianikov; Boris N Chichkov; Anand Doraiswamy; Roger J Narayan
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

8.  Micro-fractional epidermal powder delivery for improved skin vaccination.

Authors:  Xinyuan Chen; Garuna Kositratna; Chang Zhou; Dieter Manstein; Mei X Wu
Journal:  J Control Release       Date:  2014-08-15       Impact factor: 9.776

9.  Enabling skin vaccination using new delivery technologies.

Authors:  Yeu-Chun Kim; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

10.  Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.

Authors:  Suzanne M Bal; Zhi Ding; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-06-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.